The Effect of Years-Long Exposure to Low-Dose Colchicine on Renal and Liver Function and Blood Creatine Kinase Levels: Safety Insights from the Low-Dose Colchicine 2 (LoDoCo2) Trial

BACKGROUND AND OBJECTIVE: The Low-Dose Colchicine-2 (LoDoCo2) trial showed that 2–4 years exposure to colchicine 0.5 mg once daily reduced the risk of cardiovascular events in patients with chronic coronary artery disease. The potential effect of years-long exposure to colchicine on renal or liver f...

Descripción completa

Detalles Bibliográficos
Autores principales: van Broekhoven, Amber, Mohammadnia, Niekbachsh, Silvis, Max J. M., Los, Jonathan, Fiolet, Aernoud T. L., Opstal, Tjerk S. J., Mosterd, Arend, Eikelboom, John W., Nidorf, Stefan M., Budgeon, Charley A., Byrnes, Elizabeth, Bax, Willem A., Tijssen, Jan G. P., de Kleijn, Dominique P. V., Thompson, Peter L., El Messaoudi, Saloua, Cornel, Jan H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617827/
https://www.ncbi.nlm.nih.gov/pubmed/36208364
http://dx.doi.org/10.1007/s40261-022-01209-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617827/
https://www.ncbi.nlm.nih.gov/pubmed/36208364
http://dx.doi.org/10.1007/s40261-022-01209-8

Ejemplares similares